Prevalence of dysglycaemia-based chronic diasease (DBCD) in Brno, Czech Republic: a new paradigm to address diabetes burden. The Kardiovize study

• Authors: GONZALEZ-RIVAS J. P.; MECHANICK J. I.; INFANTE-GARCIA M. M.; MEDINA-INOJOSA J. R.; PAVLOVSKA Iuliia; HLINOMAZ O.; ZAK P.; KUNZOVÁ Šárka; NIETO-MARTINEZ R.; SKLADANÁ Mária; BROZ J.; HERNANDEZ J. P.; LOPEZ-JIMENEZ F.; STOKIN G. B.
• Year of publication: 2020
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: In contrast to the decreasing mortality rates observed with cardiovascular disease (CVD), mortality rates with diabetes increased by 68% in Czechia, in the last decade. The American Association of Clinical Endocrinologists developed a new framework termed Dysglycemia-Based Chronic Disease (DBCD), a multimorbidity care model consisting of 4 distinct stages along the insulin resistance-prediabetes-type 2 diabetes (T2D)-CVD spectrum, prompting a complication-centric, rather than a glucocentric approach. This paper presents the prevalence rates and associated risk factors of each DBCD stage.